Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Hill-RomHaemoneticsGlobus MedicalInspire Medical SystemsIntegra LifeSciences
SymbolNYSE:HRCNYSE:HAENYSE:GMEDNYSE:INSPNASDAQ:IART
Price Information
Current Price$113.90$116.91$68.93$224.67$70.22
52 Week RangeBuyBuyBuyBuyHold
MarketRank™
Overall Score1.81.61.41.21.4
Analysis Score1.42.51.41.41.2
Community Score2.52.22.82.42.2
Dividend Score1.70.00.00.00.0
Ownership Score1.71.70.81.71.7
Earnings & Valuation Score1.91.91.90.61.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$121.00$144.80$66.40$168.55$67.89
% Upside from Price Target6.23% upside23.86% upside-3.67% downside-24.98% downside-3.32% downside
Trade Information
Market Cap$7.56 billion$5.94 billion$6.88 billion$6.10 billion$5.92 billion
Beta0.580.561.021.711.26
Average Volume449,307395,597475,143234,125369,797
Sales & Book Value
Annual Revenue$2.88 billion$988.48 million$785.37 million$82.05 million$1.52 billion
Price / Sales2.626.018.7674.393.90
Cashflow$11.47 per share$5.18 per share$2.34 per shareN/A$4.39 per share
Price / Cash9.9322.5929.41N/A16.00
Book Value$25.92 per share$11.67 per share$14.05 per share$5.81 per share$16.50 per share
Price / Book4.3910.024.9138.674.26
Profitability
Net Income$223 million$76.53 million$155.21 million$-33,240,000.00$50.20 million
EPS$5.53$3.31$1.68($1.40)$2.74
Trailing P/E Ratio34.3156.4874.92N/A104.81
Forward P/E Ratio18.5233.3133.79N/A24.21
P/E Growth3.005.172.89N/A1.97
Net Margins7.74%11.76%12.36%-61.07%4.10%
Return on Equity (ROE)22.71%22.85%9.85%-32.23%14.26%
Return on Assets (ROA)8.01%10.40%9.04%-26.42%5.77%
Dividend
Annual Payout$0.96N/AN/AN/AN/A
Dividend Yield0.84%N/AN/AN/AN/A
Three-Year Dividend Growth22.22%N/AN/AN/AN/A
Payout Ratio17.36%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.96%0.44%N/A0.11%1.08%
Current Ratio1.43%2.25%8.12%14.67%4.52%
Quick Ratio1.06%1.34%5.80%14.18%3.31%
Ownership Information
Institutional Ownership Percentage83.75%96.22%64.35%96.30%85.71%
Insider Ownership Percentage0.65%1.63%25.63%6.60%4.30%
Miscellaneous
Employees10,0003,0042,2003413,700
Shares Outstanding66.36 million50.82 million99.80 million27.17 million84.37 million
Next Earnings Date4/30/2021 (Confirmed)5/4/2021 (Estimated)5/6/2021 (Estimated)5/4/2021 (Confirmed)4/28/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Integra LifeSciences Holdings Co. (NASDAQ:IART) COO Glenn Coleman Sells 12,500 SharesIntegra LifeSciences Holdings Co. (NASDAQ:IART) COO Glenn Coleman Sells 12,500 Shares
americanbankingnews.com - April 12 at 7:36 PM
Zacks: Analysts Expect Integra LifeSciences Holdings Co. (NASDAQ:IART) to Post $0.56 EPSZacks: Analysts Expect Integra LifeSciences Holdings Co. (NASDAQ:IART) to Post $0.56 EPS
americanbankingnews.com - April 11 at 4:14 AM
Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
finance.yahoo.com - April 8 at 7:03 PM
Is Integra LifeSciences Holdings Corporations (NASDAQ:IART) 8.8% ROE Worse Than Average?Is Integra LifeSciences Holdings Corporation's (NASDAQ:IART) 8.8% ROE Worse Than Average?
finance.yahoo.com - April 3 at 1:35 PM
Integra LifeSciences Appoints Shaundra Clay as DirectorIntegra LifeSciences Appoints Shaundra Clay as Director
finance.yahoo.com - April 1 at 5:15 PM
Heres Why You Should Retain Integra LifeSciences (IART) StockHere's Why You Should Retain Integra LifeSciences (IART) Stock
finance.yahoo.com - March 31 at 3:50 PM
Integras (IART) Neurosurgery Rebounds Despite Supply IssuesIntegra's (IART) Neurosurgery Rebounds Despite Supply Issues
finance.yahoo.com - March 31 at 10:49 AM
Integra LifeSciences Holdings Co. (NASDAQ:IART) COO Glenn Coleman Sells 15,500 SharesIntegra LifeSciences Holdings Co. (NASDAQ:IART) COO Glenn Coleman Sells 15,500 Shares
americanbankingnews.com - March 30 at 8:00 PM
Integra Lifesciences Holdings Corp (IART) Executive Vice President & COO Glenn Coleman Sold ...Integra Lifesciences Holdings Corp (IART) Executive Vice President & COO Glenn Coleman Sold ...
finance.yahoo.com - March 30 at 7:53 PM
Sometimes Stocks Move Fast, and Integra Lifesciences Hldg $IART is no ExceptionSometimes Stocks Move Fast, and Integra Lifesciences Hldg $IART is no Exception
marketwatch.com - March 27 at 1:40 AM
Integra LifeSciences Holdings Co. (NASDAQ:IART) Expected to Post Earnings of $0.56 Per ShareIntegra LifeSciences Holdings Co. (NASDAQ:IART) Expected to Post Earnings of $0.56 Per Share
americanbankingnews.com - March 24 at 4:56 PM
Integra LifeSciences Holdings Co. (NASDAQ:IART) Director Stuart Essig Sells 214,553 SharesIntegra LifeSciences Holdings Co. (NASDAQ:IART) Director Stuart Essig Sells 214,553 Shares
americanbankingnews.com - March 22 at 4:46 PM
Integra LifeSciences Holdings Co. (NASDAQ:IART) Major Shareholder Sells $5,000,066.25 in StockIntegra LifeSciences Holdings Co. (NASDAQ:IART) Major Shareholder Sells $5,000,066.25 in Stock
americanbankingnews.com - March 22 at 4:46 PM
Integra LifeSciences Holdings Co. (NASDAQ:IART) Major Shareholder Tru St Partnership, L.P. Sells 730,000 SharesIntegra LifeSciences Holdings Co. (NASDAQ:IART) Major Shareholder Tru St Partnership, L.P. Sells 730,000 Shares
americanbankingnews.com - March 22 at 4:46 PM
Integra (IART) Down 3% Since Last Earnings Report: Can It Rebound?Integra (IART) Down 3% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 20 at 12:53 PM
Integra LifeSciences Holdings Corporation Just Beat Earnings Expectations: Heres What Analysts Think Will Happen NextIntegra LifeSciences Holdings Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
finance.yahoo.com - February 26 at 7:57 AM
Integra (IART) Arms Grow Sequentially Despite Supply IssuesIntegra (IART) Arms Grow Sequentially Despite Supply Issues
nasdaq.com - February 24 at 1:09 PM
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q4 2020 Results - Earnings Call TranscriptIntegra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 20 at 6:58 AM
Integra (IART) Q4 Earnings Top Estimates, Revenues Fall Y/YIntegra (IART) Q4 Earnings Top Estimates, Revenues Fall Y/Y
nasdaq.com - February 19 at 12:42 PM
Integra LifeSciences Announces Participation in Upcoming Investor ConferencesIntegra LifeSciences Announces Participation in Upcoming Investor Conferences
finance.yahoo.com - February 19 at 12:42 PM
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides ...Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides ...
apnews.com - February 19 at 7:30 AM
Todays Role of the Software Quality EngineerToday's Role of the Software Quality Engineer
cioreview.com - February 19 at 1:23 AM
Integra LifeSciences posts earnings beat in Q4Integra LifeSciences posts earnings beat in Q4
massdevice.com - February 18 at 3:22 PM
Recap: Integra Lifesciences Q4 EarningsRecap: Integra Lifesciences Q4 Earnings
finance.yahoo.com - February 18 at 3:22 PM
Integra LifeSciences Holdings Corporation 2020 Q4 - Results - Earnings Call PresentationIntegra LifeSciences Holdings Corporation 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 18 at 1:43 PM
DateCompanyBrokerageAction
2/16/2021Hill-RomRaymond JamesBoost Price Target
2/8/2021Hill-RomMorgan StanleyBoost Price Target
2/8/2021Hill-RomRobert W. BairdBoost Price Target
11/4/2020Hill-RomNeedham & Company LLCDowngrade
10/1/2020Hill-RomKeyCorpLower Price Target
5/4/2020Hill-RomUBS GroupLower Price Target
4/14/2020Hill-RomBarclaysReiterated Rating
2/3/2021HaemoneticsBarrington ResearchUpgrade
1/21/2021HaemoneticsJMP SecuritiesBoost Price Target
3/31/2020HaemoneticsCJS SecuritiesUpgrade
2/18/2021Globus MedicalCitigroupBoost Price Target
2/18/2021Globus MedicalBTIG ResearchBoost Price Target
1/29/2021Globus MedicalPiper SandlerBoost Price Target
1/8/2021Globus MedicalCredit Suisse GroupBoost Price Target
12/8/2020Globus MedicalSmith Barney CitigroupInitiated Coverage
12/8/2020Globus MedicalCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellInitiated Coverage
10/19/2020Globus MedicalStifel NicolausInitiated Coverage
8/6/2020Globus MedicalOppenheimerInitiated Coverage
8/6/2020Globus MedicalWells Fargo & CompanyBoost Price Target
8/6/2020Globus MedicalCanaccord GenuityBoost Price Target
8/6/2020Globus MedicalNorthland SecuritiesUpgrade
8/6/2020Globus MedicalSVB LeerinkBoost Price Target
2/24/2021Inspire Medical SystemsLake Street CapitalBoost Price Target
1/4/2021Inspire Medical SystemsBank of AmericaDowngrade
12/15/2020Inspire Medical SystemsThe Goldman Sachs GroupDowngrade
9/22/2020Inspire Medical SystemsJPMorgan Chase & Co.Initiated Coverage
1/6/2021Integra LifeSciencesTruist FinancialBoost Price Target
(Data available from 4/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.